Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave N T Aryee

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cells|November 27, 2021
Mechanisms, Diagnosis and Treatment of Bone MetastasesJozef Ban, Valerie Fock, Dave N T Aryee, et al.
Cells|April 23, 2022
Zooming in on Long Non-Coding RNAs in Ewing Sarcoma PathogenesisDave N T Aryee, Valerie Fock, Utkarsh Kapoor, et al.
Oncogene|October 10, 2003
Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion proteinLaura Spahn, Christine Siligan, Radostina Bachmaier, et al.
Cancer Research|August 17, 2002
Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathwayLaura Spahn, Robert Petermann, Christine Siligan, et al.
Sarcoma|December 3, 2011
Factors Affecting EWS-FLI1 Activity in Ewing's SarcomaDavid Herrero-Martin, Argyro Fourtouna, Stephan Niedan, et al.
Pediatric Research|August 1, 2002
Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastomaDave N T Aryee, Inge Ambros, Peter F Ambros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2010
Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcomaIdriss M Bennani-Baiti, Aaron Cooper, Elizabeth R Lawlor, et al.
Oncogene|March 1, 2005
EWS-FLI1 target genes recovered from Ewing's sarcoma chromatinChristine Siligan, Jozef Ban, Radostina Bachmaier, et al.
Cancer Research|October 19, 2006
Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivoDave N T Aryee, Michael Kreppel, Radostina Bachmaier, et al.
Oncotarget|December 29, 2016
The role of miR-17-92 in the miRegulatory landscape of Ewing sarcomaRaphaela Schwentner, David Herrero-Martin, Maximilian O Kauer, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cells|November 27, 2021
Mechanisms, Diagnosis and Treatment of Bone MetastasesJozef Ban, Valerie Fock, Dave N T Aryee, et al.
Cells|April 23, 2022
Zooming in on Long Non-Coding RNAs in Ewing Sarcoma PathogenesisDave N T Aryee, Valerie Fock, Utkarsh Kapoor, et al.
Oncogene|October 10, 2003
Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion proteinLaura Spahn, Christine Siligan, Radostina Bachmaier, et al.
Cancer Research|August 17, 2002
Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathwayLaura Spahn, Robert Petermann, Christine Siligan, et al.
Sarcoma|December 3, 2011
Factors Affecting EWS-FLI1 Activity in Ewing's SarcomaDavid Herrero-Martin, Argyro Fourtouna, Stephan Niedan, et al.
Pediatric Research|August 1, 2002
Frequent low level expression in Ewing sarcoma family tumors and widespread absence of the metastasis suppressor KAI1/CD82 in neuroblastomaDave N T Aryee, Inge Ambros, Peter F Ambros, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2010
Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcomaIdriss M Bennani-Baiti, Aaron Cooper, Elizabeth R Lawlor, et al.
Oncogene|March 1, 2005
EWS-FLI1 target genes recovered from Ewing's sarcoma chromatinChristine Siligan, Jozef Ban, Radostina Bachmaier, et al.
Cancer Research|October 19, 2006
Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivoDave N T Aryee, Michael Kreppel, Radostina Bachmaier, et al.
Oncotarget|December 29, 2016
The role of miR-17-92 in the miRegulatory landscape of Ewing sarcomaRaphaela Schwentner, David Herrero-Martin, Maximilian O Kauer, et al.
Pageof 2